| Tag | Content |
|---|
EnhancerAtlas ID | HS029-07989 |
Organism | Homo sapiens |
Tissue/cell | CUTLL1 |
Coordinate | chr19:41848150-41848960 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr19:41848239-41848257 | GCTTCCTTCCTGCCTCCC | - | 7 | | ZNF263 | MA0528.1 | chr19:41848206-41848227 | GGAGGAAGAGGAAGGAAGGAG | + | 6.56 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_18470 | chr19:41847459-41848365 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_19170 | chr19:41847684-41848397 | CD4p_CD25-_Il17p_PMAstim_Th17 | | SE_22408 | chr19:41847457-41848304 | CD8_primiary |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH19I041341 | chr19 | 41847430 | 41848397 |
|
Enhancer Sequence | CCCTGTAGGA GTGGCGAGAG GGAAGCCAGT CTGAGAGTGC AGCTCACCCA GCCCCTGGAG 60
GAAGAGGAAG GAAGGAGCAA ACCCCAGGGG CTTCCTTCCT GCCTCCCCCA CCCACCCCAC 120
TCTGCCCTCT CACTGCAGCT CTCTCTTTTT TTTTTTTTTT TTTTTTTTGA GACAAGGTCT 180
CGCAGCCTCA ATCTCCAAGG CCCAAGCAAT CCTCCCATCT CAGCCTCCCG AGTAGCTGGG 240
ACCACAGGCG CGTGCTACCA CGCATGGCTA ATTTTTTTTT TTTTTTTGAG ATGGAGTCTG 300
GCTCTGTTGC CCAGGCTGGA GTTCAGTGGC GTGATATCAG CTCACTGCAA CCTCCACCTC 360
CCAGGTTCAA ACGATTCTCC TGCCTCAGCC TCCCAAGTAG CTGGGATAAC AGGCATGCGC 420
CACCACACCC GGCTAATTTT TTGTATTTTT AGTAGAGATG GGGTTTCACC ATGCTGGCCA 480
GGCTGGTCTC AAACTCCTGA CCTCAGGTGA TCCGCCTGCC TTGGCATCCC AAAGTGCTGG 540
GATTACAGGC TTGAGCCACT GCATCCGGCC TACACGGCTA CTTTTTAAAT TCTCTGTAGA 600
GACAGAGGTC TCACTATGTT GCCCAGGCTG GGCTCAAGCA ATCCTCCTGC CCTGGCCTCC 660
CGAAGTGCTG GGATTACAGG CATGAGCCAC TGCACCCAGC CAGCATCAAT CTCTTGAATG 720
AATGAGTGAA TGATGTTTTC TAGGCTCCTA CAATGTGCCG AAGCCTGTGC TGTGTGCTTG 780
GGACTCAGCA TTGACCAAGA CAGATGAGCT 810
|
